leisure time -WSS

leisure time

author：knowledge 2025-09-27 22:06:05 - browse：6

An orange Flovent inhaler on a white background. -- health coverage from STAT — Adobe

As of Jan. 1, thousands of asthma patients in the U.S. will no longer be able to get refills for Flovent — one of the most popular inhalers in the U.S. for nearly 30 years.

Flovent’s manufacturer, GSK, has discontinued both versions of the product — Flovent HFA, an inhalation aerosol, and Flovent Diskus, an inhalation powder — and replaced each with what is known as an “authorized generic,” essentially the same product sold under a private label. Prasco, a U.S. drugmaker specializing in authorized generics, will distribute the new inhaler, sold as fluticasone.

The timing of the change is telling: Flovent’s price rose nearly 50% since 2014, according to GoodRx, leaving the drug vulnerable to the new Medicaid penalties going into effect as of this year for medications with price increases that outpace inflation. By discontinuing the brand-name inhaler but continuing to earn money from the authorized generic, GSK will be able to avoid paying a penalty.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： 2 officers injured in shooting in Orlando, police say

WSS

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

How CO2 helps viruses stay alive longer in the air

BD to buy Edwards patient monitoring unit for $4.2 billion

FDA approves Moderna’s RSV vaccine, its second licensed product

Pharma showers House GOP doctor with campaign cash

For pregnant people, addiction treatment shouldn't mean a call to child protective services

Wikipedia

leisure time

focus

Supreme Court strikes down use of affirmative action

Chris Christie meets with Zelenskyy during Ukraine trip

Psychedelics group wrestles with new pharma identity

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

As demand for Covid shots wanes, Moderna seeks its next success

FDA approves Sage Therapeutics’ rapid

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Stopping antidepressants leads to symptoms for 1 in 6 patients

How to save PrEP access — and even expand it

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

entertainment

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Study links childhood stress with decline in older age

Anthony Fauci pushes back on GOP claims during Covid hearing

How to ethically and practically extend health care to all

CMS got Medicare Advantage quality rating wrong, judge rules

Chris Christie meets with Zelenskyy during Ukraine trip

Wikipedia

leisure time

explore

knowledge